Opening Remarks: Dr Andrew Plump, President of Research & Development, Takeda

Panel: BioPharma Investment Priorities

Panelists:
Dr. Francesco De Rubertis, Co-founder & Partner, Medicxi
Dr. Kris Jenner, Co-Founder & Managing Member, Rock Springs Capital
Rajiv Kaul, Sector Portfolio Manager, Fidelity Investments
Dr. Stephen Knight, President & Senior Managing Partner, F-Prime Capital

Moderator:
Dr. Stelios Papadopoulos, Chairman of the Board, Exelixis, Inc.

Panel: R&D strategies in an era of unprecedented uncertainty and opportunity

Panelists:
Dr. Andrew Plump, President of Research & Development, Takeda
Dr. David Meeker, Chairman & CEO, Rhythm Pharmaceuticals
Dr. Maria Freire, Principal, The Freire Group
Dr. Mathai Mammen, Chairman & CEO, Parabilis Medicines

Moderator:
Dr. Kush Parmar, Managing Partner, 5AM Ventures

Panel: Digital & Data Science in Healthcare

Panelists:
Dr. Belen Fraile, Chief R&D Data Science Officer, Johnson & Johnson Innovative Medicine
Dr. Dina Katabi, Professor of Computer Science, Massachusetts Institute of Technology (MIT)
Dr. Nicole Glazer, Senior Vice President R&D Data, Takeda
Parag Saxena, Co-Founder & Managing Partner, Vedanta Capital
Dr. Paul Burton, Chief Medical Officer, Amgen

Moderator:
Sastry Chilukuri, Chairman & CEO, Emmes Group

Panel: BioPharma- Measures for Unpredictable Times

Panelists:
Christopher Viehbacher, President & CEO, Biogen
Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group
Sanat Chattopadhyay, President- Manufacturing, Merck & Co.
Dr. Susan Hockfield, President Emerita, Massachusetts Institute of Technology (MIT)

Moderator:
Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

Panel: Oncology

Panelists:
Dr. Michael Morrissey, President & CEO, Exelixis
Dr. Paul-Peter Tak, President & CEO, Candel Therapeutics
Dr. Steve Harr, President & CEO, Sana Biotechnology
Dr. Sam Waksal, Founder, Chairman & CEO, Graviton Biosciences
Dr. Toni Choueiri, Director, Genitourinary (GU) Oncology, Dana-Farber Cancer Institute

Moderator:
Dr. Najat Khan, Chief R&D and Commercial Officer, Recursion

Panel: Clinical Trials Opportunities in India

Panelists:
Badhri Srinivasan, Executive Chairman, Unilabs
Dr. Christoph Koenen, Head of Clinical Development & Operations, Pharma R&D, Bayer
Dinkar Saran, Partner- Pharma and Life Sciences Operations, PwC
Peyton Howell, Chief Executive Officer, Parexel
Dr. Sarah Sheikh, Head of Global Development, Takeda

Moderator:
Peter Ronco, Chief Executive Officer, Emmes

Panel: Rare & Neuro Diseases

Panelists:
Daphne Zohar, Founder & Chief Executive Officer, Seaport Therapeutics
Dr. Fiona Elwood, Vice President, Neurodegeneration DAS, J&J Innovative Medicine
Dr. Priya Singhal, Executive Vice President & Head of Development, Biogen
Dr. Nancy Andrews, Executive Vice President & CSO, Boston Children’s Hospital
Dr. Zandy Forbes, President & CEO, MeiraGTx

Moderator:
Dr. Steve Uden, Co-Founder & CEO, Rallybio

Honouring Dr. Stelios Papadopoulos, Chairman of the Board, Exelixis, Inc. with the Distinguished Service Award

Panel: BioPharma Industry & Investment Outlook

Panelists:
Christopher Viehbacher, President & CEO, Biogen
Dilip Shanghvi, Founder & Managing Director, Sun Pharmaceutical Industries
Hari Bhartia, Founder and Co-Chairman, Jubilant Bhartia Group
Rajiv Kaul, Sector Portfolio Manager, Fidelity Investments
Dr. Stelios Papadopoulos, Chairman of the Board, Exelixis

Moderator:
Daphne Zohar, Founder & Chief Executive Officer, Seaport Therapeutics

Panel: Industry Academic Partnerships

Panelists:
Dr Andrew Plump, President of Research & Development, Takeda
Dr. George Daley, Dean, Harvard Medical School
Dr. Marc Tessier-Lavigne, President Emeritus, Stanford University
Dr. Noubar Afeyan, Founder & Chief Executive Officer, Flagship Pioneering

Moderator:
Dr. Elias Zerhouni, Vice Chairman & President, OPKO Health

Panel: Clinical Trials Opportunities in India

Panelists:
Badhri Srinivasan, Head, Global Clinical Operations, Novartis
Dr. Christopher Corsico, Global Head of Development, GSK
Peyton Howell, Chief Operating & Growth Officer, Parexel
Dr. Sarah Sheikh, Head of Global Development, Takeda
Dr. Uli Broedl, SVP, Head of Global Clinical Development, Boehringer Ingelheim

Moderator:
Peter Ronco, Chief Executive Officer, Emmes

Panel: Research & Development Strategies and Trends

Panelists:
Dr Andrew Plump, President of Research & Development, Takeda
Dr. Jane Grogan, Executive Vice President and Head of Research, Biogen
Dr. Mathai Mammen, Chairman & CEO, FogPharma
Dr. Robert Plenge, EVP, Chief Research Officer, Head of Research, Bristol Myers Squibb

Moderator:
Dr. Martin Mackay, Co-Founder, Rallybio

Panel: Digital & Data Science in Healthcare

Panelists:
Dr. Dina Katabi, Professor of Computer Science, MIT
Dr. Jason Kelly, Co-Founder & CEO, Ginkgo Bioworks
Dr. Krishna Yeshwant, Managing Partner, Google Ventures
Michael Nally, Chief Executive Officer, Generate:Biomedicines
Sastry Chilukuri, Chairman & CEO, Emmes Group

Moderator:
Dr. Najat Khan, Chief Data Science Officer, Johnson & Johnson Innovative Medicine

Panel: Rare & Neuro Diseases

Panelists:
Dr. David Meeker, Chairman & CEO, Rhythm Pharmaceuticals
Dr. Ed Kaye, President & CEO, Stoke Therapeutics
Dr. James Wilson, Director- Gene Therapy Program, University of Pennsylvania
Josh Mandel-Brehm, President & CEO, CAMP4
Dr. Priya Singhal, Executive Vice President & Head of Development, Biogen

Moderator:
Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

Panel: Oncology

Panelists:
Dr. Bruce Chabner, Director of Clinical Research, Cancer Center, Mass General Hospital
Dr. Claire Mazumdar, Chief Executive Officer, Bicara Therapeutics
Phuong Khanh (P.K.) Morrow, Head of the Oncology Therapeutic Area Unit, Takeda
Dr. Simrit Parmar, Founder, Cellenkos
Dr. Zandy Forbes, President & CEO, MeiraGTx

Moderator:
Dr. Sam Waksal, Founder, Chairman & CEO, Graviton Biosciences

Welcome address: Karun Rishi, President, USAIC Opening comments by Chair and Master of Ceremonies (Emcee): Dr. Andrew Plump

Welcome address: Karun Rishi, President, USAIC Opening comments by Chair and Master of Ceremonies (Emcee): Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical

Fireside Chat: Dr. Robert Califf moderated by Dr. William Chin

Fireside Chat: Dr. Robert Califf, Commissioner of Food and Drugs, US Food and Drug Administration
Moderator: Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

Fireside Chat: Joaquin Duato moderated by Kenneth Frazier

Fireside Chat: Joaquin Duato, Chairman & CEO, Johnson & Johnson
Moderator: Kenneth Frazier, Chairman, Health Assurance Initiatives, General Catalyst and former Chairman & CEO, Merck & Co.

Fireside Chat: Dr. Albert Bourla moderated by Dr. Stelios Papadopoulos

Fireside Chat: Dr. Albert Bourla, Chairman and Chief Executive Officer, Pfizer
Moderator: Dr. Stelios Papadopoulos, Chairman, Biogen

Panel: BioPharma R&D and Global Supply Chain agenda at G20

Panelists:
Amitabh Kant, G20 Sherpa, G20
Dr. Krishna Ella, Chairman & Managing Director, Bharat Biotech
Sanat Chattopadhyay, President- Manufacturing, Merck & Co.
Moderator: 
Kiran Mazumdar-Shaw, Executive Chairperson, Biocon

Panel: Clinical Trials Opportunities in India

Panelists:
Badhri Srinivasan, Head, Global Clinical Operations, Novartis
Dr. Cynthia Verst, President, Design & Delivery Innovation for R&D Solutions, IQVIA
Dr. Naresh Trehan, Chairman, Medanta – the Medicity
Dr. Shiv Kumar Sarin, Chancellor, Institute of Liver and Biliary Sciences
Dr. Vinod Paul, Member, National Institution for Transforming India, the NITI Aayog
Moderator:
Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical

Panel: Research and Development Strategies and Trends

Panelists:
Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical
Dr. Daniel Skovronsky, Executive Vice President, Chief Scientific and Medical Officer, Eli Lilly and Company
Dr. David Reese, Executive Vice President, Research and Development, Amgen
Dr. Fiona Marshall, President, Novartis Institutes for BioMedical Research
Moderator:
Dr. Martin Mackay, Co-Founder, Rallybio

Panel: Industry Academic Partnerships

Panelists:
Dr. Elias Zerhouni, Vice Chairman & President, OPKO Health
Dr. Marcus Schindler, Executive Vice President, Research & Early Development and Chief Scientific Officer, Novo Nordisk
Dr. Mathai Mammen, CEO Designate, FogPharma
Dr. Phillip Sharp, Institute Professor, Koch Institute, MIT
Dr. Priya Singhal, Executive Vice President & Head of Development, Biogen
Moderator:
Dr. Susan Hockfield, President Emerita, MIT

Panel: Digital & Data Science

Panelists:
Dr. Alice Zhang, Co-Founder & CEO, Verge Genomics
Dr. Anne Heatherington, Head of Data Sciences Institute, Takeda Pharmaceuticals
Dr. Dina Katabi, Professor of Computer Science, Member – CSAIL, Massachusetts Institute of Technology
Dr. Junaid Bajwa, Chief Medical Scientist, Microsoft
Sastry Chilukuri former Co-CEO, Medidata

Moderator:
Dr. Najat Khan, Chief Data Science Officer and Global Head of Janssen R&D Strategy and Operations, Janssen R&D, Johnson & Johnson

Panel: Oncology

Panelists:
Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic
Dr. Frank Nestle, Global Head of Research and Chief Scientific Officer, Sanofi
Dr. Kathy Seidl, Vice President, Head of the Oncology Drug Discovery Unit, Takeda
Dr. Katy Rezvani, Professor of Medicine, Chief of Section for Cellular Therapy, Director of Translational Research, MD Anderson Cancer Center
Rehan Verjee, Co-Founder & Chief Executive Officer, Stealth start-up
Moderator:
Dr. James Bradner, Physician Scientist, Former President, Novartis Institutes for BioMedical Research

Panel: BioPharma Industry & Investment Outlook

Panelists:
Daphne Zohar, Founder & Chief Executive Officer, PureTech Health
Christopher Viehbacher, President & CEO, Biogen
Rajiv Kaul, Portfolio Manager, Fidelity Investments
Dr. Stephen Knight, President & Managing Partner, F-Prime Capital
Theresa Tse, Chairwoman of Board Committee, Sino Biopharmaceutical Limited
Moderator:
Dr. Samuel Waksal, Chairman and Chief Executive Officer, Graviton Biosciences

Closing Remarks by Dr. Andrew Plump

Closing Remarks: Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical

Welcome address: Karun Rishi, President, USAIC

Welcome address: Karun Rishi, President, USAIC

Opening comments by Dr. Andrew Plump

Opening comments: Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals

Moving Closer to Cure for More Cancer Patients

Panelists:
Dr. Christine Ward, Vice President, Head of Oncology and Cell Therapy, Takeda Pharmaceuticals
Dr. Eric Rubin, Senior Vice President, Therapeutic Area Head Oncology, Early Development, Merck Research Labs
Dr. Samarth Kulkarni, Chief Executive Officer, CRISPR Therapeutics
Dr. Sam Waksal, Chairman and Chief Executive Officer, Equilibre Biopharmaceuticals
Dr. Todd Golub, Director and Founding Core Member, Broad Institute of MIT & Harvard

Moderator:
Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic

Fireside Chat: Alex Gorsky moderated by Christopher Viehbacher

Fireside Chat: Alex Gorsky, Executive Chairman, Johnson & Johnson
Moderator: Christopher Viehbacher, Founding Partner, Gurnet Point Capital

Clinical Trials Landscape in India

Panelists:
Dr. Cynthia Verst, President, Design & Delivery Innovation for Research and Development Solutions, IQVIA
Dr. Kush Parmar, Managing Partner, 5AM Ventures
Dr. Naresh Trehan, Chairman, Medanta
Peter Ronco, Head of Global Development, Janssen Research and Development, Johnson & Johnson
Dr. Vinod Paul, Member, National Institution for Transforming India, the NITI Aayog

Moderator:
Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals

Digital & Data Science Panel

Panelists:
Daphne Zohar, Founder & Chief Executive Officer, PureTech Health
Dr. Karen Akinsanya, President of Research and Development, Therapeutics, Schrodinger
Dr. Regina Barzilay, Professor of AI and Health, Massachusetts Institute of Technology
Sastry Chilukuri, Co-Chief Executive Officer, Medidata
Dr. Vipin Gopal, Chief Data & Analytics Officer, Eli Lilly

Moderator:
Chris Benko, Co-Founder and Chief Executive Officer, Koneksa Health

Pandemics: Where does the world go from here

Dr. Larry Tabak, Acting Director, National Institutes of Health (NIH)
Dr. John Mascola, Chief Scientific Officer, ModeX Therapeutics
Dr. Julie Gerberding, Chief Executive Officer, Foundation for the NIH (FNIH)
Kiran Mazumdar-Shaw, Executive Chairperson, Biocon

Moderator:
Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University

Industry & Investment Outlook Panel

Panelists:
Christopher Viehbacher, Founding Partner, Gurnet Point Capital
Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group
Rajiv Kaul, Portfolio Manager, Fidelity Investments
Dr. Stelios Papadopoulos, Chairman of the Board, Biogen

Moderator:
Jennifer Fox, Chief Financial Officer, Nuvation Bio

Rethinking Rare: Resolutions for reinvention in a genomic age

Panelists:
Dr. Alfred Sandrock, Chief Executive Officer, Voyager Therapeutics
Charlene Son Rigby, Chief Executive Officer, RARE-X
Paula Soteropoulos, Chairman of the Board, Ensoma
Dr. Philip Larsen, Global Head of Research, Bayer Pharma
Max Bronstein, Assistant Director for Health Innovation, White House Office of Science & Technology Policy

Moderator:
Dr. Timothy Yu, Associate Professor in Pediatrics, Harvard Medical School

Research and Development Strategies & Trends Panel

Panelists:
Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals
Dr. David Reese, Executive Vice President, Research and Development, Amgen
Dr. John Reed, Global Head of Research and Development, Sanofi
Dr. Mathai Mammen, Executive Vice President, Pharmaceuticals, Research and Development, Johnson & Johnson

Moderator: 
Dr. Martin Mackay, Co-Founder, Rallybio

Closing Remarks

Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals, Advisory Board Members and Speakers

Welcome address by Karun Rishi, President, USAIC

Welcome address: Karun Rishi, President, USAIC

Opening comments by Dr Andrew Plump

Opening comments: Dr Andrew Plump, President of R&D, Takeda Pharmaceuticals

Fireside Chat with Dr. Albert Bourla moderated by Dr. Stelios Papadopoulos

Dr. Albert Bourla, Chairman & CEO, Pfizer
Dr. Stelios Papadopoulos, Chairman of the Board, Biogen

Fireside Chat with Dr. Janet Woodcock moderated by Dr. William Chin

Dr. Janet Woodcock, Acting Commissioner, U.S. Food and Drug Administration
Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

R&D Strategies & Trends Panel

Panelists: Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals, Dr. David Reese, Executive Vice President, Research and Development, Amgen, Dr. John Reed, Global Head of R&D, Sanofi, Dr. Mathai Mammen, Global Head of Janssen R&D, Johnson & Johnson
Moderator: Dr. Martin Mackay, Co-Founder, Rallybio

India Innovation Panel

Panelists: Amitabh Kant, Chief Executive Officer, National Institution for Transforming India, Dilip Shanghvi, Managing Director, Sun Pharmaceutical Industries Limited, Prof. K. Vijay Raghavan, Principal Scientific Advisor, Government of India, Dr. Naresh Trehan, Chairman, Medanta Hospital
Moderator: Sanat Chattopadhyay, President- Merck Manufacturing Division, Merck & Co.

Fireside Chat: Robert Bradway moderated by Kiran Mazumdar-Shaw

Fireside Chat: Robert Bradway, Chairman & CEO, Amgen
Moderator: Kiran Mazumdar-Shaw, Executive Chairperson, Biocon

Fireside Chat with Dr. Francis Collins moderated by Dr. Elias Zerhouni

Fireside Chat: Dr. Francis Collins, Director, National Institutes of Health, Dr. Margaret Hamburg, Former Commissioner, U.S. Food and Drug Administration
Moderator: Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University

Oncology Panel

Panelists: Dr. Bruce Chabner, Director of Clinical Research, Massachusetts General Hospital Cancer Center, Dr. Carrie Brownstein, Chief Medical Officer, Cellectis, Dr. Philip Larsen, Global Head of Research, Bayer AG, Dr. Sam Waksal, Founder, MeiraGTx, Vivek Ramaswamy, Founder & Executive Chairman, Roivant Sciences
Moderator: Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic

Industry & Investment Outlook Panel

Panelists: Christopher Viehbacher, Managing Partner, Gurnet Point Capital, Dr. Peter Orszag, Chief Executive Officer – Financial Advisory, Lazard Freres, Rajiv Kaul, Portfolio Manager, Fidelity Investments, Dr. Stelios Papadopoulos, Chairman, Biogen
Moderator: Daphne Zohar, Co-Founder and Chief Executive Officer, PureTech Health

Digital & Data Science Panel

Panelists: Craig Kennedy, Senior Vice President, Merck & Co., Dr. Daphne Koller, Founder & CEO, insitro, Dr. Karen Akinsanya, Chief Biomedical Scientist, Schrödinger, Dr. Najat Khan, Chief Data Science Officer, Janssen Research & Development, Dr. Robert Califf, Head of Clinical Policy & Strategy, Verily & Google Health
Moderator: Sastry Chilukuri, President, Acorn AI- Medidata

Rare Disease Panel

Panelists: Dr. David Meeker, Chairman & CEO, Rhythm Pharmaceuticals, Dr. Frank Bennett, Chief Scientific Officer, Ionis Pharmaceuticals, Dr. John Orloff, Head of Research & Development, Alexion, Dr. Katherine High, President – Therapeutics, AskBio, Majid Jafar, Co-Founder, Loulou Foundation
Moderator: Dr. Alfred Sandrock, Head of Research and Development, Biogen

Closing Remarks by Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals

Welcome address by Karun Rishi, President, USAIC

Opening Address by Andrew Plump

Opening comments:  Dr Andrew Plump, President of R&D, Takeda Pharmaceuticals

COVID-19 Panel – Where are we now? Where are we going?

Panelists: Dr. Barry Bloom, Professor & former Dean, Harvard School of Public Health; Dr. George Yancopoulos, Co-Founder, President & CSO, Regeneron; Kiran Mazumdar-Shaw, Executive Chairperson, Biocon; Dr. Rajeev Venkayya, President of the Global Vaccine Business Unit, Takeda; Dr. Richard Hatchett, CEO, Coalition for Epidemic Preparedness Innovations (CEPI)
Moderator: Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

India Regulatory Update

Dr. Mandeep Bhandari, Joint Secretary, Ministry of Health & Family Welfare, India; Dr. V G Somani, Drug Controller General of India, Central Drug Control Organization
Moderator: Muna Bhanji, Senior Vice President,  Merck & Co.

Fireside Chat with Kenneth Frazier moderated by Stelios Papadopoulos

Kenneth Frazier, Chairman of the Board and Chief Executive Officer, Merck & Co.
Dr. Stelios Papadopoulos, Chairman of the Board, Biogen

India Innovation Landscape Panel

Panelists: Amitabh Kant, Chief Executive Officer, National Institution for Transforming India (NITI); Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group; Dr. K. Vijay Raghavan, Principal Scientific Advisor, Government of India; Dr. Naresh Trehan, Chairman, Medanta – the Medicity
Moderator: Sanat Chattopadhyay, President, Merck Manufacturing Division; Merck & Co.

Oncology panel discussion: Changing landscape- COVID learnings and the promise of new technologies

Panelists: Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic; Dr. Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute; Dr. Philip Larsen, Global Head of Research, Bayer AG; Rehan Verjee, President, EMD Serono; Dr. Tony Ho, Head of Research and Development, CRISPR Therapeutics
Moderator: Dr. Raju Kucherlapati, Professor of Genetics, Harvard Medical School

Industry & Investment Outlook Panel Discussion

Panelists: Christopher Viehbacher, Managing Partner, Gurnet Point Capital; Daphne Zohar, Founder & CEO, PureTech Health; Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University; Dr. Stelios Papadopoulos, Chairman, Biogen
Moderator: Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals

Rare Diseases panel: No longer forgotten; but more to be achieved

Panelists: Dr. Alfred Sandrock, Executive Vice President, Research & Development, Biogen; Dr. Daniel Curran, Head of the Rare Diseases Therapeutic Area Unit, Takeda; Dr. David Meeker, Chairman & CEO , Rhythm Pharmaceuticals; Dr. John Orloff, Head of Research & Development, Alexion; Matt Wilsey, Co-Founder & Chairman, Grace Science Foundation
Moderator: Dr. Steve Uden, Co-Founder, Rallybio

Fireside Chat with Roy Vagelos moderated by Mathai Mammen

Dr. Roy Vagelos, Chairman of the Board, Regeneron Pharmaceuticals
Dr. Mathai Mammen, Global Head of Janssen Research & Development, Johnson & Johnson

Digital & Data Science in Healthcare Panel: Pragmatic Insights from the Real-World

Panelists: Dr. Anne Heatherington, Head of Data Sciences Institute, Takeda Pharmaceuticals; Arpa Garay, President, Global Pharmaceuticals, Commercial Analytics, Merck & Co.; Dr. Maya Said, Chief Executive Officer, Outcomes4Me; Dr. Najat Khan, Chief Operating Officer, Janssen R&D Data Sciences, Johnson & Johnson; Nina Kjellson, General Partner, Canaan
Moderator: Sastry Chilukuri, President, Acorn AI- Medidata

R&D Strategies and Trends Panel: Innovation- The Big I

Panelists: Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals; Dr. David Reese, Executive Vice President, Research and Development, Amgen; Dr. Hal Barron, Chief Scientific Officer and President R&D, GlaxoSmithKline; Dr. Mathai Mammen, Global Head of Janssen Research & Development, Johnson & Johnson
Moderator: Dr. Martin Mackay, Co-Founder, Rallybio

Closing Remarks by Andrew Plump, President of R&D, Takeda